Clinical trials
Patient Safety clinical trials
Below are recruiting patient safety clinical trials, each written for real people, not researchers. We’re tracking 1,353 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06205121RecruitingPhase 2
Testing a new drug for active lung sarcoidosis
This study tests a new medication, OATD-01, for people with active sarcoidosis in their lungs. It aims to see how safe and effective the drug is and if it can improve symptoms.
Birmingham, AlabamaAges 18 years+ - NCT06278454RecruitingPhase 1
Radioactive injection for advanced pancreatic cancer
This trial tests a new radioactive injection called NRT6008 for people with pancreatic cancer that cannot be surgically removed. It aims to see if the treatment can shrink the tumor and improve survival.
Zhengzhou, HenanAges 18–80 - NCT06296212RecruitingPhase 3
Testing TAD injection to protect the heart during pneumonia
This trial tests if a medicine called TAD® (glutathione injection) can help prevent heart injury in people hospitalized with pneumonia. It is for patients who also have heart risks or conditions, and takes place in the hospital.
Pisa, PIAges 18–80 - NCT06328712RecruitingPhase 1/Phase 2
Cell therapy for Charcot-Marie-Tooth type 1A (CMT1A)
This trial tests a new cell therapy called EN001 for people with CMT1A. It aims to see if the treatment is safe and can help with nerve function and muscle weakness.
GyeongjuAges 19 years+ - NCT06392477RecruitingPhase 1
Testing a new drug for relapsed B-cell lymphoma
This trial tests an experimental drug, SAR448501/DR-0201, for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink tumors.
Camperdown, New South WalesAges 18 years+ - NCT06429761RecruitingPhase 4
Safety study of Trastuzumab Deruxtecan in Indian patients with breast cancer
This study tests the safety of the drug Trastuzumab Deruxtecan (T-DXd) in Indian patients with a specific type of advanced breast cancer (called HER2-positive) that has spread and cannot be removed by surgery. It is for patients who have already received anti-HER2 treatment.
BangaloreAges 18 years+ - NCT06439771RecruitingPhase 2
Testing YL202 for advanced breast cancer
This trial tests a new drug called YL202 for people with advanced breast cancer. It is for those who have already tried certain targeted treatments (HER2 or TROP2 antibody-drug conjugates) and they stopped working. The goal is to see if YL202 can help shrink tumors or slow cancer growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06462547RecruitingPhase 2
Long-term safety study of INZ-701
This long-term safety study looks at the drug INZ-701 for people with two rare conditions called ENPP1 and ABCC6 deficiencies. If you already took part in an earlier study of this drug, this trial will monitor you over a longer period to see how safe and well it works over time.
Rochester, MinnesotaAges 1 year+ - NCT06503237Recruiting
SWK002 for tough-to-treat rheumatoid arthritis
This trial tests a new treatment called SWK002 for people with rheumatoid arthritis that hasn't improved after trying multiple medications. It aims to see if SWK002 can help when other treatments have failed.
Changsha, HunanAges 18 years+ - NCT06515132Recruiting
Spinal cord stimulation for consciousness after brain injury
This trial tests whether spinal cord stimulation can help people who have been minimally conscious for months after a brain injury. It aims to improve awareness and responsiveness by using mild electrical pulses.
Fuzhou, FujianAges 18–65 - NCT06537076RecruitingPhase 2
Testing AR1005 for Lewy body dementia
This trial tests an experimental oral medication called AR1005 for people with Lewy body dementia or its early stage. It aims to see if the drug is safe and helps with memory, thinking, and daily function.
SeoulAges 60 years+ - NCT06549673Recruiting
Stopping beta blocker in controlled cirrhosis
This study is checking if it is safe for people with cirrhosis (liver scarring) to stop taking a certain blood pressure medicine (non-selective beta blockers) if their main liver problem is under control. If you've had varices or bleeding in the past and your liver is now stable, this trial will see if you can safely stop the medicine.
SydneyAges 18 years+ - NCT06552416RecruitingPhase 1
Safety study of MT-401-OTS for relapsed AML or MDS
This trial tests a new cell therapy called MT-401-OTS for people aged 65 or older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The goal is to see if this treatment is safe and to find the right dose.
Duarte, CaliforniaAges 65 years+ - NCT06562738RecruitingPhase 4
Hetrombopag for low platelets before surgery
This trial tests whether the drug hetrombopag can safely raise platelet counts in people with immune thrombocytopenia (ITP) before they have surgery. The goal is to reduce bleeding risk during and after the operation.
Chengdu, SichuanAges 18 years+ - NCT06572267RecruitingPhase 2
Meplazumab for coronary artery disease
This trial tests if meplazumab can help people with chronic coronary syndrome who have stable angina. It focuses on patients with certain fatty deposits around their heart arteries that show up on a special CT scan.
Xi'an, ShannxiAges 18 years+ - NCT06596915RecruitingPhase 1
BA1302 for advanced solid tumors
This trial tests a new drug, BA1302, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to see if BA1302 is safe and effective.
BeijingAges 18 years+ - NCT07566195RecruitingPhase 3
Long-term Safety of Tozorakimab in COPD Patients
This study follows patients who previously took part in a tozorakimab trial to see how safe the drug is over time. Tozorakimab is an antibody treatment designed to reduce flare-ups (exacerbations) in people with COPD, a chronic lung disease.
Aix-en-ProvenceAges 18–99 - NCT06616714Recruiting
Weight loss procedure for people with obesity and IBD
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty (a stomach-reducing procedure done through a scope) in people with both obesity and inflammatory bowel disease (IBD). It aims to see if the procedure is safe and helpful for this group.
RomaAges 18–70 - NCT06618573RecruitingPhase 2/Phase 3
Can isoniazid prevent TB in lupus patients?
This study tests if taking the TB prevention medicine isoniazid is safe for people with lupus (SLE). It may help protect you from getting tuberculosis while managing your lupus.
Bandung, West JavaAges 18–55 - NCT06647069RecruitingPhase 1
Testing a new drug for lupus and rheumatoid arthritis
This study tests an investigational drug called SAR448501/DR-0201 in people with active lupus or rheumatoid arthritis who have not responded well to standard treatments. The goal is to see if the drug is safe and helps control disease activity.
Brisbane, QueenslandAges 18–75 - NCT06647550RecruitingPhase 2
Testing a new pill for type 2 diabetes not well controlled by diet and exercise
This trial tests a new medication, HD-6277, to see if it can help lower blood sugar in adults with type 2 diabetes that isn't well managed by diet and exercise alone.
SeoulAges 19–75 - NCT06660719RecruitingPhase 3
New stroke medicine SP-8203 with clot-busting therapy
This trial tests a new medicine called SP-8203 added to standard clot-busting treatment for people having a moderate to severe stroke. The goal is to see if it helps improve recovery and is safe.
BusanAges 19–85 - NCT06666946Recruiting
Electroacupuncture for sepsis patients in the ICU
This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.
Wuhan, HubeiAges 18 years+ - NCT06745622RecruitingPhase 2
Long-term safety of HSK39297 for PNH patients
This study is for people with paroxysmal nocturnal hemoglobinuria (PNH) who have already taken the experimental drug HSK39297. It checks the long-term safety of continuing the treatment and makes sure it is still helpful.
Nanjing, JiangsuAges 18 years+
Hear when a new Patient Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient safety?
- Yes. Clin2 currently lists 1,353 recruiting patient safety studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient safety trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient safety trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.